The demand for private GP services in the UK is driving the growth of the country’s private GP Electronic Health Record (EHR) market. Factors include a scarcity of NHS GPs and technological advances integrating AI and wearable tech with EHRs. Privacy concerns and technological issues may however limit market growth.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
